APA

Grabig A., Paclik D., Guzy C., Dankof A., Baumgart D. C., Erckenbrecht J., Raupach B., Sonnenborn U., Eckert J., Schumann R. R., Wiedenmann B., Dignass A. U. & Sturm A. (20060824). Escherichia coli strain Nissle 1917 ameliorates experimental colitis via toll-like receptor 2- and toll-like receptor 4-dependent pathways. : Infection and immunity.

Chicago

Grabig A, Paclik D, Guzy C, Dankof A, Baumgart D C, Erckenbrecht J, Raupach B, Sonnenborn U, Eckert J, Schumann R R, Wiedenmann B, Dignass A U and Sturm A. 20060824. Escherichia coli strain Nissle 1917 ameliorates experimental colitis via toll-like receptor 2- and toll-like receptor 4-dependent pathways. : Infection and immunity.

Harvard

Grabig A., Paclik D., Guzy C., Dankof A., Baumgart D. C., Erckenbrecht J., Raupach B., Sonnenborn U., Eckert J., Schumann R. R., Wiedenmann B., Dignass A. U. and Sturm A. (20060824). Escherichia coli strain Nissle 1917 ameliorates experimental colitis via toll-like receptor 2- and toll-like receptor 4-dependent pathways. : Infection and immunity.

MLA

Grabig A, Paclik D, Guzy C, Dankof A, Baumgart D C, Erckenbrecht J, Raupach B, Sonnenborn U, Eckert J, Schumann R R, Wiedenmann B, Dignass A U and Sturm A. Escherichia coli strain Nissle 1917 ameliorates experimental colitis via toll-like receptor 2- and toll-like receptor 4-dependent pathways. : Infection and immunity. 20060824.